http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946291-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7b9f8bc98245b9c3c846ec99efacf9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0d57266162f0324ccb5ed4b6fe25e42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575 |
filingDate | 2008-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e843de64b8ed37988107ff833be76931 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_024fd645b2bad3a0fee50c64bf978da0 |
publicationDate | 2015-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-8946291-B2 |
titleOfInvention | Compositions and methods for treating pigmentary conditions and melanoma |
abstract | A method of treating melanoma in a subject comprising administering an amount of SOX9 sufficient to treat melanoma is disclosed. A method of treating a hyperpigmentary condition in a subject comprising administering an amount of inhibitor of SOX9 activity sufficient to treat the condition is disclosed. A method of treating melanoma in a subject comprising administering an amount of SOX9 sufficient to treat melanoma is disclosed. A method of treating melanoma in a subject comprising increasing the amounts of retinoic acid and SOX9 in the subject by amounts sufficient to treat melanoma. A method of treating melanoma in a subject comprising administering an amount of prostaglandin D2 and retinoic acid sufficient to treat cancer is disclosed. A method of sensitizing a melanoma cell to RA comprising administering an amount of SOX9 sufficient to decrease PRAME expression is disclosed. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014289882-A1 |
priorityDate | 2008-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2516.